News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–72
- Matches
- 1393
- Sources here
- 13
- Companies here
- 15
Active search
1393 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Covenant Asset Management LLC Sells 2,765 Shares of JPMorgan Chase & Co. $JPM
Covenant Asset Management LLC reduced its stake in JPMorgan Chase & Co. (NYSE:JPM) by 9.9% in the second quarter, selling 2,765 shares and retaining 25,140 shares valued at $8.23 million. Institutional investors hold a significant portion of the stock, and analysts maintain a "Moderate …
Wall Street Zen Upgrades Alta Equipment Group (NYSE:ALTG) to "Hold"
Wall Street Zen has upgraded Alta Equipment Group (NYSE:ALTG) from a "sell" to a "hold" rating, resulting in a consensus "Hold" rating for the stock with an $8.75 price target. This upgrade comes despite the company missing its latest quarterly earnings expectations, reporting a …
PMV Pharmaceuticals (NASDAQ:PMVP) Posts Earnings Results, Beats Expectations By $0.05 EPS
PMV Pharmaceuticals (NASDAQ:PMVP) reported a quarterly loss of $0.34 per share, beating analyst expectations by $0.05. Following the announcement, the stock rose 3.7% to $1.26. Analysts maintain a "Moderate Buy" rating with a $4.00 consensus price target, despite Oppenheimer lowering its target to $5.00.
JPMorgan debanked Polymarket last year over regulatory concerns, source says
JPMorgan Chase reportedly terminated its banking relationship with prediction market platform Polymarket in October of last year due to regulatory concerns. While a source indicated this debanking, Polymarket claims to maintain a close relationship with JPMorgan, with its CEO having spoken at three of …
Alta Equipment Group (ALTG) Q2 2026 Earnings Call Transcript
Alta Equipment Group reported a positive inflection point in Q2 2026, with significant sequential growth in revenue and Adjusted EBITDA driven by improving market conditions and strategic shifts toward organic growth and capital efficiency. The company highlighted strengthening industrial indicators and increased backlog in …
EquipmentShare.com Inc. Notice of September 21, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Kahn Swick & Foti, LLC (KSF) has issued a notice to investors in EquipmentShare.com Inc. (NASDAQ: EQPT) regarding a class action securities lawsuit. The lawsuit alleges that EquipmentShare and its executives failed to disclose material information in connection with its January 2026 IPO and …
Peyto Exploration & Development Corp. Confirms Monthly Dividend for September 15, 2026
Peyto Exploration & Development Corp. CALGARY, Alberta, Aug. 14, 2026 (GLOBE NEWSWIRE) -- Peyto Exploration & Development Corp. (TSX: PEY) ("Peyto") confirms that the monthly dividend with respect to August 2026 of $0.12 per common share is to be paid on September 15, 2026, …
EquipmentShare.com Reports Q2 2026 Results: Full Earnings Call Transcript
EquipmentShare.com reported strong Q2 2026 results, with a 39% increase in rental segment revenue and 55% margins at mature rental locations. The company authorized a $500 million share repurchase program and provided a full-year rental segment revenue growth outlook of approximately 33%, despite a …
JPMorganChase Dividend Declaration Covers Series II, OO and PP
JPMorgan Chase & Co. (NYSE: JPM) has declared dividends on its Series II, OO, and PP preferred stock. The financial services firm reported $5.0 trillion in assets and $375 billion in stockholders’ equity as of June 30, 2026, and is a global leader in …
EquipmentShare.com Inc. (EQPT) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP has announced a securities fraud class action lawsuit against EquipmentShare.com Inc. (EQPT), inviting shareholders who suffered losses between January 23, 2026, and June 23, 2026, to become lead plaintiffs. The lawsuit alleges that EquipmentShare.com Inc. failed to disclose …
PMV Pharmaceuticals Releases Q2 2026 Financial Results
PMV Pharmaceuticals reported a narrower loss for Q2 2026, with a loss of $0.34 per share compared to $0.41 in the prior year, marking a 17.1% improvement. The precision oncology company recorded a net loss of $18.1 million as it continues to invest in …
JPMorgan Chase & Co. Has Lowered Expectations for BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price
JPMorgan Chase & Co. has lowered its price target for BridgeBio Oncology Therapeutics (NASDAQ:BBOT) from $27 to $25, while maintaining an "overweight" rating, implying a potential upside of 172.12%. Despite the reduction, analyst sentiment remains largely positive with a "Moderate Buy" consensus and an …
JPMorgan Spots Something Unusual in Hot Stocks
This article first appeared on GuruFocus. J.P. Morgan (NYSE:JPM) says one of Wall Street's hottest trades has developed an unusual valuation advantage: momentum stocks are now cheaper than the broader S&P 500 on a forward earnings basis. The reversal matters because investors historically have …
What Does JPMorgan Chase (JPM) Olympic Deal And Banking Exit Mean Now?
Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. JPMorgan Chase (NYSE:JPM) has been named the first global banking partner of the Olympic and Paralympic Games, marking a new worldwide sponsorship role for the bank. The …
JPMorgan Resets Knicks Valuation After Lakers Deal
This article first appeared on GuruFocus. Madison Square Garden Sports (NYSE:MSGS) is getting a powerful new valuation signal after JPMorgan estimated the New York Knicks are worth $11.75 billion, following a record-setting Los Angeles Lakers transaction that reset expectations for marquee NBA franchises. The …
Meteora Capital (TDAC) discloses 919,000-share beneficial stake in SPAC
Meteora Capital, LLC and its managing member Vik Mittal, have reported a beneficial ownership of 919,000 shares of Translational Development Acquisition Corp. (TDAC) Class A Common Stock, which constitutes 6.27% of the class. This stake is held by funds and managed accounts where Meteora …
JPMorgan Cut Polymarket Banking Ties Over Regulatory Concerns
JPMorgan Chase ended its banking relationship with prediction market Polymarket in October 2025 due to regulatory concerns, specifically an enforcement action by the Commodity Futures Trading Commission (CFTC) that prevented Polymarket from serving U.S. customers. Despite this, Polymarket maintains it still has a "close, …
JPMorgan Chase & Co. Has Lowered Expectations for Globant (NYSE:GLOB) Stock Price
JPMorgan Chase & Co. has reduced its price target for Globant (NYSE:GLOB) from $47 to $44, while maintaining a "neutral" rating, indicating an 18.4% potential upside. This adjustment reflects a broader cautious sentiment among analysts, as Globant's recent financial results showed mixed performance with …
JPMorgan set a serious Microsoft stock price target for 2027
Microsoft stock spent most of 2026 in the penalty box. The AI spending looked too heavy. The returns were not yet visible. Then the company reported fourth-quarter results on July 29, and the stock jumped more than 27%. Azure crossed $100 billion. Copilot showed …
JPMorgan Chase & Co. Increases Yesway (NASDAQ:YSWY) Price Target to $27.00
JPMorgan Chase & Co. has raised its price target for Yesway (NASDAQ:YSWY) from $25.00 to $27.00, maintaining a "neutral" rating on the stock, which implies a potential upside of 9.67%. This adjustment comes amidst mixed analyst sentiment, with Yesway holding an average "Moderate Buy" …
JPMorgan Chase & Co. Raises Madison Square Garden (NYSE:MSGS) Price Target to $485.00
JPMorgan Chase & Co. has increased its price target for Madison Square Garden (NYSE:MSGS) from $450.00 to $485.00, maintaining an "overweight" rating. This new target suggests a potential upside of 19.63% from the stock's previous close. The company's stock, which saw a 1.8% decline …
Bronstein, Gewirtz & Grossman LLC Urges EquipmentShare.com Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against EquipmentShare.com Inc. (NASDAQ: EQPT) alleging federal securities law violations. The lawsuit claims that EquipmentShare made materially false and misleading statements regarding undisclosed related-party transactions and the company's financial condition. Investors who purchased …
Translational Development Acquisition (TDAC): Linden Advisors reports 6.7% ownership stake
Linden Advisors and related entities, including Siu Min (Joe) Wong, have reported a significant ownership stake in Translational Development Acquisition Corp. (TDAC). They beneficially own 1,150,000 Class A Ordinary Shares, which constitutes approximately 6.7% of the outstanding shares as of June 30, 2026. This …
Rare Earth Stocks Soar on Friday: MP Materials Up 8%, USA Rare Earth Up 9%, NioCorp Up 3%. What’s Behind the Jump?
Quick Read MP Materials surged 8% and USA Rare Earth jumped 9% Friday on trader speculation about U.S. tariff support, with no confirmed catalyst. Rare earth stocks price in tariff probability before any announcement, rewarding holders if policy lands but punishing them sharply if …
StemPoint group (XLO) discloses 9.5% Xilio Therapeutics stake via warrants
StemPoint Capital LP, StemPoint Capital Management GP LLC, and Michelle Ross have collectively reported a 9.5% beneficial ownership in Xilio Therapeutics, Inc. (XLO) through an SEC Schedule 13G/A filing. Their stake comprises 628,866 shares of common stock, primarily derived from pre-funded, Series A, and …
JPMorgan Chase: How To Limit Risk On A Stock That's Doing Well
Traders might consider taking some bullish exposure on JPMorgan stock, using options in a limited risk way. Continue Reading
Morgan Stanley, JPMorgan Increase Crypto ETF Holdings in Q2
Major US banks Morgan Stanley (NYSE: $MS) and JPMorgan (NYSE: $JPM) increased their holdings of cryptoinvestment products in the second quarter, adding to their exposure to Bitcoin (CRYPTO: $BTC) and Ethereum (CRYPTO: $ETH) ETFs despite market volatility during the period. Morgan Stanley increased its …
JPMorgan Turns Bullish on Salesforce as the Stock Runs Three Straight Weeks
Quick Read JPMorgan turned bullish on CRM after a 20% monthly surge; our $276 price target implies 37% upside from current levels. Salesforce trades at a steep discount to MSFT and NOW despite Agentforce ARR surging 205% year-over-year to $1.2 billion. Act now: the …